Safety and dose optimization for [11C] DMDPA as a PET imaging agent for evaluation of myocardial perfusion in subjects with known or suspected coronary artery disease (CAD).
Phase of Trial: Phase II
Latest Information Update: 24 Dec 2018
At a glance
- Drugs Carbon-11 dimethyl diphenyl ammonium (Primary)
- Indications Coronary artery disease
- Focus Adverse reactions
- 03 Nov 2017 New trial record